Shprintzen RJ, Goldberg RB. A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias. J Craniofac Genet Dev Biol. 1982;2:65–74.
Greally MT, Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al. editors. Shprintzen-Goldberg Syndrome. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993.2006 Jan 13 [updated 2020 Apr 9].
Arnaud P, Racine C, Hanna N, Thevenon J, Alessandri JL, Bonneau D, et al. A new mutational hotspot in the SKI gene in the context of MFS/TAA molecular diagnosis. Hum Genet. 2020;139:461–72.
Srivastava P, Shende S, Mandal K. Deciphering the Pathogenic Nature of Two de novo Sequence Variations in a Patient with Shprintzen-Goldberg Syndrome. Mol Syndromol. 2021;12:141–7.
Shi J, Sun J, Chen Y, Zhu M, Wang Q, Lu C. et al. Analysis of phenotype and genetic variant in a family with Shprintzen-Goldberg syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022;39:703–7.
Suzuki H, Yagi K, Kondo M, Kato M, Miyazono K, Miyazawa K. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Oncogene. 2004;23:5068–76.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, Schepers D, et al. Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat Genet. 2012;44:1249–54.
Gori I, George R, Purkiss AG, Strohbuecker S, Randall RA, Ogrodowicz R, et al. Mutations in SKI in Shprintzen-Goldberg syndrome lead to attenuated TGF-beta responses through SKI stabilization. Elife 2021;10:e63545.
Ueki N, Hayman MJ. Signal-dependent N-CoR requirement for repression by the Ski oncoprotein. J Biol Chem. 2003;278:24858–64.
Wu W, Wang X, Yu X, Lan HY. Smad3 signatures in renal inflammation and fibrosis. Int J Biol Sci. 2022;18:2795–806.
Wilson JJ, Malakhova M, Zhang R, Joachimiak A, Hegde RS. Crystal structure of the dachshund homology domain of human SKI. Structure. 2004;12:785–92.
Miyazono KI, Ohno Y, Wada H, Ito T, Fukatsu Y, Kurisaki A, et al. Structural basis for receptor-regulated SMAD recognition by MAN1. Nucleic Acids Res. 2018;46:12139–53.
Kim SS, Zhang RG, Braunstein SE, Joachimiak A, Cvekl A, Hegde RS. Structure of the retinal determination protein Dachshund reveals a DNA binding motif. Structure. 2002;10:787–95.
Thielen NGM, van der Kraan PM, van Caam APM. TGFbeta/BMP signaling pathway in cartilage homeostasis. Cells. 2019;8:969.
Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res. 2005;33:W382–W388.
Huang SS, Huang JS. TGF-beta control of cell proliferation. J Cell Biochem. 2005;96:447–62.
Wallden K, Nyman T, Hallberg BM. SnoN stabilizes the SMAD3/SMAD4 protein complex. Sci Rep. 2017;7:46370.
Carrozzo R, Torraco A, Fiermonte G, Martinelli D, Di Nottia M, Rizza T, et al. Riboflavin responsive mitochondrial myopathy is a new phenotype of dihydrolipoamide dehydrogenase deficiency. The chaperon-like effect of vitamin B2. Mitochondrion. 2014;18:49–57.
Pietropaolo A, Pierri CL, Palmieri F, Klingenberg M. The switching mechanism of the mitochondrial ADP/ATP carrier explored by free-energy landscapes. Biochim Biophys Acta. 2016;1857:772–81.